Du är här


KLOX Technologies Inc. : Colgate-Palmolive and Klox Technologies Enter Into Agreements for Oral Health

NEW YORK and LAVAL, Quebec, Feb. 08, 2016 (GLOBE NEWSWIRE) --
Colgate-Palmolive Company ("Colgate") and Klox Technologies Inc. ("KLOX")
have entered into agreements to globally commercialize and further develop
KLOX's human Oral Health technology platform. The agreements include a
worldwide license to commercialize KLOX's proprietary Biophotonic technology
in the field of human Oral Health and an equity investment in KLOX by
Dr. Lise Hébert, President and CEO of KLOX, stated: "We are extremely pleased
to have Colgate-Palmolive, the leader in Oral Care, with activities in over
200 countries and territories be our global partner for our Oral Health
platform. These agreements once again recognize the breadth of our technology
platform. Furthermore, these agreements validate the value creation strategy
we have adopted by partnering large potential indications with first in class
partners, while building a specialized salesforce for products within Wound

Suzan Harrison, President of Global Oral Care of Colgate, stated: "We are very
pleased to have KLOX as a partner in the development of this exciting and new
technology platform for the benefit of Oral Health."

About Colgate-Palmolive Company


Colgate-Palmolive is a leading global consumer products company, tightly
focused on Oral Care, Personal Care, Home Care and Pet Nutrition. Colgate
sells its products in over 200 countries and territories around the world
under such internationally recognized brand names as Colgate, Palmolive,
Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sorriso,
Kolynos, elmex, Tom's of Maine, Sanex, Ajax, Axion, Fabuloso, Soupline and
Suavitel, as well as Hill's Science Diet, Hill's Prescription Diet and Hill's
Ideal Balance. For more information about Colgate's global business, visit
the Company's web site at http://www.colgatepalmolive.com. To learn more
about Colgate Bright Smiles, Bright Futures® oral health education program,
please visit http://www.colgatebsbf.com.

About Klox Technologies Inc.:
KLOX is a specialty pharmaceutical company focused on developing and
commercializing products based on its proprietary Biophotonic technology
platform to address skin and soft tissue disorders. The company has a
multi-franchise platform focusing on indications across Dermatology, Wound
Care, and Oral Health.

To learn more about KLOX, please visit http://www.kloxtechnologies.com.
Colgate-Palmolive Company Media Contact:

Mitali Chopra - mitali_chopra@colpal.com

Klox Technologies Inc. Media Contact:
Mr. Michael Rice - mrice@lifesciadvisors.com


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: KLOX Technologies Inc. via Globenewswire


Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.